| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Other income | 0.1 | 0.1 | 0.1 |
| Total income | 23.3 | 13.0 | 11.8 |
| Net profit | 3.7 | 2.9 | 2.5 |
| Operating margin | 21.5% | 30.8% | 30.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +48.00% |
|---|---|
| Net profit, quarter on quarter | +27.60% |
BSE results filing, NSE: GKSL. Figures extracted from the filing.
Gujarat Kidney and Super Speciality Ltd: key numbers
- Share price
- ₹175.89
- Market cap
- ₹1,387 Cr
- Revenue (annual)
- ₹82.01 Cr
- Net profit (annual)
- ₹15.50 Cr
- P/E (TTM)
- 87.6×Sector 56.3×
- Promoter holding
- 71.45%+0.00% QoQ
- FII holding
- 4.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Kidney and Super Speciality Ltd
All →Gujarat Kidney and Super Speciality Annual Report
Gujarat Kidney and Super Speciality Limited issued a corrigendum to its FY 2025-26 Annual Report. The update includes missing Secretarial Audit observations and management responses.
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited has issued a notice for its 7th Annual General Meeting scheduled for September 28, 2026. The meeting will address financial statements, director appointments, and related party transactions.
- Value
- ₹1.78 Cr
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited filed a revised Annual Report for FY 2025-26. The document also includes the notice for its 7th Annual General Meeting.
Gujarat Kidney and Super Speciality Annual Report
Gujarat Kidney & Superspeciality Limited released its Annual Report for FY 2025-26. The report includes the notice for the 7th AGM scheduled for September 28, 2026.
Gujarat Kidney and Super Speciality Management Change
Gujarat Kidney and Super Speciality Ltd appointed Mrs. (Dr) Disha Bharpoda as an Additional Non-Executive Independent Director. The Board also noted shareholder approval for IPO proceeds usage.
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney And Superspeciality Limited shareholders approved a special resolution via postal ballot. The resolution authorizes variation in the objects/terms of utilization of IPO proceeds.